Article

barrons.com on 2022-04-28 14:21

Merck Beats Earnings Estimates. The Stock Is Up. 3 min read

The stronger-than-expected earnings reflect both the blockbuster sales of Merck's new Covid-19 antiviral pill, but also a steady recovery from the ...

Related news